Injection of Autologous Adipose Tissue for Treatment of Osteoarthritis in the Knee

Exclusion Criteria

• •1. Participants who have had surgery of either knee within 6 months prior to the screening visit.
• •2. Participants who have had a major injury to either knee within 12 months prior to enrolling in the study.
• •3. Participants who have had an injection in either knee in the prior 6 months, including corticosteroids, viscosupplementation or platelet rich plasma (PRP).
• •4. Participants who have gout, rheumatoid arthritis, lupus arthropathy, psoriatic arthritis, avascular necrosis, severe bone deformity, infection of the knee joint, fibromyalgia, pes anserine bursitis, or neurogenic or vascular claudication.
• •5. Participants who have symptomatic OA of the hips, spine, or ankle that would interfere with the evaluation of the treated knee.
• •6. Participants that are unwilling to stop taking prescription pain medication 7 days prior to any visit.
• •7. Participants that are allergic to lidocaine, epinephrine or valium
• •8. History of bleeding disorders, anticoagulation therapy that cannot be stopped 3 days prior to injection
• •9. Subjects that use any form of tobacco to include e-cigarettes more than once a week within the last 6 months